Food and Drug Administration

First Page		Document Content
Food and Drug Administration Antitussives Dissociative drugs Dextromethorphan Morphinans Adverse Event Reporting System Center for Drug Evaluation and Research Cough medicine Recreational use of dextromethorphan Pharmacology Neurochemistry Medicine		Food and Drug Administration Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 96,89 KB Share Document on Facebook

	ARTICLE Neonatal Deaths After Hepatitis B Vaccine The Vaccine Adverse Event Reporting System, Manette T. Niu, MD; Marcel E. Salive, MD, MPH; Susan S. Ellenberg, PhD DocID: 1sU4r - View Document
	84521booklet 1_TK-letter-size DocID: 1qPpC - View Document
	QuarterWatch Monitoring FDA MedWatch Reports Why Reports of Serious Adverse Drug Events Continue to Grow October 3, 2012 Data from 2012 Quarter 1 DocID: 1p1ui - View Document
	YELLOW FEVER VACCINE ADVERSE EVENT REPORTING SYSTEM PATIENT IDENTITY KEPT CONFIDENTIAL WEBSITE: www.enivd.de E-MAIL: Phone: ++For internal Use Only Robert Koch Institut, Nordu DocID: 1eA92 - View Document
	YELLOW FEVER VACCINE ADVERSE EVENT REPORTING SYSTEM PATIENT IDENTITY KEPT CONFIDENTIAL WEBSITE: www.enivd.de E-MAIL: FAX: ++For internal Use Only Robert Koch Institut, Nordufer 20 DocID: 1drvk - View Document